SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

GLENMARK PHARMACEUTICALS

BSE: 532296 19 Aug 2025
Healthcare
₹ 1945.9
Glenmark Pharmaceuticals ltd specializes in Pharmaceuticals within the Healthcare sector.

GLENMARK PHARMACEUTICALS - Share Price & Details

Market Cap
₹54,897
High /Low
2,286 / 1,275
Stock P/E
41.2
Book Value
₹314.0
Dividend Yield
0.13
ROCE
19.4
ROE
₹15.8
Face Value
1.0
PEG Ratio
6.59
EVEBITDA
₹22.7
Debt
2,473
CMP / FCF
-61.9
Debt to equity
₹0.28
NP Ann
1,047
High price all time
2,286
Piotroski score
₹5.0
Graham Number
434.0
No. Eq. Shares
28.2
Net CF
₹-38.5
Net profit
754
Price to book value
6.2
Interest Coverage
₹8.66
Low price all time
109.0
Industry PE
33.5
Reserves
₹8,821
Free Cash Flow
₹-1,575

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
GLENMARK PHARMACEUTICALS LTD.24642.633302.2623949.2811.754,89741.2
BIOCON LTD.5984.0-83.05371.0-0.0748659134.0
Laurus Labs Limited14542.71579.414327.52.934773293.8

Peer Comparison Chart


About GLENMARK PHARMACEUTICALS

Glenmark Pharmaceuticals ltd, with Security Code 532296, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

CDSCO Panel Accepts Glenmark's Apremilast Trial Report, Seeks 2-Year PSUR Data

(11 Aug 2025)
New Delhi: Glenmark Pharmaceuticals Limited has received approval from the Subject Expert Committee (SEC), functioning under the Central...
Read more →

Glenmark Pharma share price falls 2.1% in today's session; stock among top losers on Nifty Midcap 150

(09 Aug 2025)
With the stock's last traded price at Rs 2019.50, Glenmark Pharma is currently trading among the top losers on the Nifty Midcap 150.
Read more →

Glenmark Pharma Shares Gain as Arm Reaches Settlement in US Antitrust Suit

(08 Aug 2025)
Shares of Glenmark Pharmaceuticals Ltd were trading 1% higher after Glenmark Pharmaceuticals Inc., USA, reached a $37.75 million settlement...
Read more →

Glenmark Pharmaceuticals' USA arm reaches $37.75 million settlement in US antitrust lawsuit

(07 Aug 2025)
Glenmark Pharmaceuticals Ltd on Wednesday (August 7) said its subsidiary Glenmark Pharmaceuticals Inc., USA, has agreed to a $37.75 million...
Read more →

Glenmark Pharmaceuticals Ltd spurts 1.22%, up for third straight session

(30 Jul 2025)
Glenmark Pharmaceuticals Ltd is quoting at Rs 2171.5, up 1.22% on the day as on 12:49 IST on the NSE. The stock is up 50.76% in last one...
Read more →

Glenmark Pharmaceuticals Limited (532296) Stock Experiences Sudden Dip - Remarkable growth

(23 Jul 2025)
Glenmark Pharmaceuticals Limited (532296) Stock Experiences Sudden Dip ✌️【Market Discussions】✌️ Experience smarter investing with...
Read more →

Company Updates